Be yourself; Everyone else is already taken.
— Oscar Wilde.
This is the first post on my new blog. I’m just getting this new blog going, so stay tuned for more. Subscribe below to get notified when I post new updates.
Serious Injuries Linked to Zantac®
Based on results of Lab testing, the Food and Drug Administration has determined that Zantac® and other ranitidine based medicines have a nitrosamine issue named N–nitrosodimethylamine (NDMA) at lower concentrations. NDMA is known as a probable human carcinogen – a substance might cause cancer in humans. NDMA is a known environmental contaminant and observed in water supplies and food sources, including meat, dairy items, and vegetables.
What is NDMA?
N–nitrosodimethylamine (NDMA) is considered as a probable human carcinogen that means that it’s more probable than not to cause cancer in humans. NDMA has been researched in animal populations and observed to increase the creation of cancer in the animals. The studies have enhanced the chance of an association between NDMA and liver toxicity that may lead to the development of liver cancer and various related conditions brought about by an NDMA–induced treatment of the liver.
The amount and length of human NDMA exposure which may begin the development of cancer is not exactly known. Similarly, the extent and duration of the NDMA contamination of Zantac® and various ranitidine medications are not precisely known.
Diseases Connected with Exposure to NDMA
NDMA has been studied in animal populations and determined to increase the occurrence of cancer in the animals. In light of these studies, the Environmental Protection Agency classifies NDMA as a likely human carcinogen. The studies have increased the likeliness of a connection between NDMA and liver toxicity which can lead to the creation of liver cancer and other related issues due to an NDMA injury to the liver. Others have suggested that NDMA could also be linked to other cancers such as:
Stomach Cancer, Colorectal Cancer, Prostate Cancer, Non–Hodgkin’s Lymphoma.
Has Other Ranitidine Products Been Affected?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the possibility of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired quantities and lots of ranitidine hydrochloride medication because of the possibility of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medicines?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
zantac lawsuit is a leading consumer advocate for the recovery of damages due to NDMA exposure. Feel free to reach out at any time to explore your injury and potential for recovery.
What is NDMA?
N–nitrosodimethylamine (NDMA) is considered as a probable human carcinogen that means that it’s more probable than not to cause cancer in humans. NDMA has been researched in animal populations and observed to increase the creation of cancer in the animals. The studies have enhanced the chance of an association between NDMA and liver toxicity that may lead to the development of liver cancer and various related conditions brought about by an NDMA–induced treatment of the liver.
The amount and length of human NDMA exposure which may begin the development of cancer is not exactly known. Similarly, the extent and duration of the NDMA contamination of Zantac® and various ranitidine medications are not precisely known.
Diseases Connected with Exposure to NDMA
NDMA has been studied in animal populations and determined to increase the occurrence of cancer in the animals. In light of these studies, the Environmental Protection Agency classifies NDMA as a likely human carcinogen. The studies have increased the likeliness of a connection between NDMA and liver toxicity which can lead to the creation of liver cancer and other related issues due to an NDMA injury to the liver. Others have suggested that NDMA could also be linked to other cancers such as:
Stomach Cancer, Colorectal Cancer, Prostate Cancer, Non–Hodgkin’s Lymphoma.
Has Other Ranitidine Products Been Affected?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the possibility of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired quantities and lots of ranitidine hydrochloride medication because of the possibility of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medicines?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
zantac lawsuit is a leading consumer advocate for the recovery of damages due to NDMA exposure. Feel free to reach out at any time to explore your injury and potential for recovery.
Health Issues Connected to Zantac®
Due to results of laboratory evaluation, the U.S. FDA has determined that Zantac® and other ranitidine medications have a nitrosamine issue called N–nitrosodimethylamine (NDMA) at low amounts. NDMA is thought of as a likely human carcinogen – a substance that could cause cancer in humans. NDMA is a classified environmental contaminant and found in water and foods, including meat, dairy items, and vegetables.
What is NDMA?
N–nitrosodimethylamine (NDMA) is known as a probable human carcinogen that means that it’s more likely than not to cause cancer in humans. NDMA has been studied in animal populations and found to increase the occurrence of cancer in the animals. The research has increased the chance of an association between NDMA and liver toxicity that may lead to the development of liver cancer and various connected conditions created by an NDMA–induced reaction to the liver.
The amount and length of human NDMA exposure that may begin the development of cancer is not precisely known. Also, zantac lawsuit and length of the NDMA contamination of Zantac® and other ranitidine medicines are not exactly known.
Diseases Associated with Exposure to NDMA
NDMA has been researched in animal groups and determined to increase the happening of cancer in the animals. Based on these studies, the Environmental Protection Agency classifies NDMA as a probable human carcinogen. The research has raised the probability of an association between NDMA and liver toxicity that can lead to the development of liver cancer and other associated issues due to an NDMA injury to the liver. Some have suggested that NDMA might also be linked to other cancers such as:
Stomach Cancer, Esophageal Cancer, Kidney Cancer, Non–Hodgkin’s Lymphoma.
Have Other Ranitidine Products Been Affected?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the possibility of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride medication due to the potential of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup because of the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medications?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer law firm for the recovery of damages because of to NDMA exposure. Feel free to contact us at any time to discuss your injury and potential for recovery.
What is NDMA?
N–nitrosodimethylamine (NDMA) is known as a probable human carcinogen that means that it’s more likely than not to cause cancer in humans. NDMA has been studied in animal populations and found to increase the occurrence of cancer in the animals. The research has increased the chance of an association between NDMA and liver toxicity that may lead to the development of liver cancer and various connected conditions created by an NDMA–induced reaction to the liver.
The amount and length of human NDMA exposure that may begin the development of cancer is not precisely known. Also, zantac lawsuit and length of the NDMA contamination of Zantac® and other ranitidine medicines are not exactly known.
Diseases Associated with Exposure to NDMA
NDMA has been researched in animal groups and determined to increase the happening of cancer in the animals. Based on these studies, the Environmental Protection Agency classifies NDMA as a probable human carcinogen. The research has raised the probability of an association between NDMA and liver toxicity that can lead to the development of liver cancer and other associated issues due to an NDMA injury to the liver. Some have suggested that NDMA might also be linked to other cancers such as:
Stomach Cancer, Esophageal Cancer, Kidney Cancer, Non–Hodgkin’s Lymphoma.
Have Other Ranitidine Products Been Affected?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the possibility of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired amounts and lots of ranitidine hydrochloride medication due to the potential of NDMA in the medication.
Lannett Company, Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup because of the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medications?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Consultation
Meneo Law Group is a leading consumer law firm for the recovery of damages because of to NDMA exposure. Feel free to contact us at any time to discuss your injury and potential for recovery.
Introduce Yourself (Example Post)
This is an example post, originally published as part of Blogging University. Enroll in one of our ten programs, and start your blog right.
You’re going to publish a post today. Don’t worry about how your blog looks. Don’t worry if you haven’t given it a name yet, or you’re feeling overwhelmed. Just click the “New Post” button, and tell us why you’re here.
Why do this?
- Because it gives new readers context. What are you about? Why should they read your blog?
- Because it will help you focus you own ideas about your blog and what you’d like to do with it.
The post can be short or long, a personal intro to your life or a bloggy mission statement, a manifesto for the future or a simple outline of your the types of things you hope to publish.
To help you get started, here are a few questions:
- Why are you blogging publicly, rather than keeping a personal journal?
- What topics do you think you’ll write about?
- Who would you love to connect with via your blog?
- If you blog successfully throughout the next year, what would you hope to have accomplished?
You’re not locked into any of this; one of the wonderful things about blogs is how they constantly evolve as we learn, grow, and interact with one another — but it’s good to know where and why you started, and articulating your goals may just give you a few other post ideas.
Can’t think how to get started? Just write the first thing that pops into your head. Anne Lamott, author of a book on writing we love, says that you need to give yourself permission to write a “crappy first draft”. Anne makes a great point — just start writing, and worry about editing it later.
When you’re ready to publish, give your post three to five tags that describe your blog’s focus — writing, photography, fiction, parenting, food, cars, movies, sports, whatever. These tags will help others who care about your topics find you in the Reader. Make sure one of the tags is “zerotohero,” so other new bloggers can find you, too.
The Blogging of Justesen 748 